Coronavirus (COVID-19) information for Dana-Farber patients & familiesLearn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request alive medical interpreter for a discussion about your care.
Menu
For Patients & Families
右为Ursula Matulonis博士(Ursula Matulonis, MD)
美国每年约有1万至1.1万女性被确诊患有宫颈癌(cervical cancer)。随着很多女性已经进行常规性的宫颈癌筛查,在美国,这种癌症的发病率(incidence)和死亡率(death rates)至少降低了80%。
“在美国,子宫颈涂片筛查(Pap smear,也称巴氏涂片)帮助人们提高了对宫颈癌的防患意识,它也是帮助降低宫颈癌确诊频率的一大助力”,Ursula Matulonis博士(Ursula Matulonis, MD)说道。她是丹娜—法伯研究所苏珊∙F∙史密斯女性癌症中心(Susan F. Smith Center for Women’s Cancers at Dana-Farber)妇科肿瘤学的医学主任。